Israel lastly allowed to export medical hashish abroad – firebird-cbdoil


After years of delays, Israel's medical cannabis industry can finally export its products to other countries.

Israel has been a leader in medical marijuana research since the 1960s, and the country's open-minded laws have allowed researchers to develop a range of creative new cannabis products. Legislators quickly recognized the economic potential to enable the domestic pot industry to sell their products overseas and in 2017 proposed to legalize the export of medicinal cannabis products.

Later this year, several Israeli cannabis breeders with large-scale growing phases started, hoping to sell their products internationally. In early 2018, Prime Minister Benjamin Netanyahu stifled these hopes and blocked the export bill on fears that weeds planted by Israel would end up on the black market. Nonetheless, legislators insisted on their proposal and officially legalized the export of medical marijuana last December.

The adoption of this law renewed the interest of foreign investors in the Israeli cannabis industry, which quickly faded as the prospect of exports slowed down again. At the request of President Trump, Prime Minister Netanyahu tried to delay the implementation of this law for almost a full year. This month's delays could come to an end as the government finally approved the export law.

Israeli medical cannabis companies are now allowed to export their products technically, but there is still a catch. Before international exports are allowed, the local cannabis industry must first be able to meet domestic demand for medical weeds. Unfortunately, there has been a shortage of medical cannabis in Israel since one of the country's biggest growers, Tikun Olam, was temporarily shut down due to concerns over its drying process.

Laura Kam, President of Kam Global Strategies, a communications firm with many clients in the Israeli cannabis industry, described to Forbes the current situation as follows: "In recent years, substantial investment in cannabis farms and technologies has been made in Israel but due to bureaucratic clashes and now with a janitorial government unable to give final approval to export their crops as flower, oil, or any other form, is very scared in the Israeli cannabis ecosystem. "

Kam explained that many foreign investors "have decided to invest their funds and technological know-how outside the country, to build farms in places like Malta and Uganda, and to invest in cannabis companies around the world, from Poland to to the USA USA to Australia and elsewhere. "

This may now change as the export moratorium is lifted, but Israeli cannabis companies still have to overcome a number of other regulatory hurdles before they can start selling their goods overseas. For example, to import goods into Europe, companies must comply with Europe-certified Good Manufacturing Practices (Eu-GMP) – and many Israeli cannabis companies do not yet meet these complicated regulations.